S-1 and irinotecan plus bevacizumab versus mFOLFOX6 or CapeOX plus bevacizumab as first-line treatment in patients with metastatic colorectal cancer (TRICOLORE): a randomized, open-label, phase 3, non-inferiority trial
| Image |  |
|---|---|
| Description | scientific article published on 27 December 2017 |
| Author/s |
author: S Takahashi Tatsuro Yamaguchi |
| Publication date | March 1, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |